What is EBR Systems?
Founded in 2003, EBR Systems specializes in advanced cardiac rhythm management solutions, most notably its leadless WiSE Cardiac Resynchronization Therapy system. This innovative technology offers a more physiologic approach to cardiac pacing, addressing the limitations of traditional therapies. The company serves healthcare professionals and institutions across North America and Oceania, aiming to improve patient outcomes in cardiac care. EBR Systems operates within both B2B and B2C segments, driving advancements in medical technology for heart conditions.
How much funding has EBR Systems raised?
EBR Systems has raised a total of $200.9M across 10 funding rounds:
Unspecified
$15M
Series D
$5M
Private Equity
$18.7M
Private Equity
$20M
Private Equity
$50M
Other Financing Round
$30M
Debt
$1M
Unspecified (2009): $15M featuring Split Rock Partners and Delphi Ventures
Series D (2011): $5M, investors not publicly disclosed
Private Equity (2014): $18.7M with participation from ReShape Lifesciences, Delphi Ventures, Split Rock Partners, and The Foundry
Private Equity (2015): $20M led by Emergent Medical Partners, Delphi Ventures, Split Rock Partners, and SV Life Sciences
Private Equity (2017): $50M supported by Brandon Capital Partners, Split Rock Partners, Emergent Medical Partners, Ascension Ventures, and M.H. Carnegie & Co
Other Financing Round (2019): $30M featuring Ascension Ventures, M.H. Carnegie & Co., Brandon Capital Partners, Split Rock Partners, and Dr. Thomas Fogarty’s Emergent Medical Partners
Debt (2020): $1M backed by PPP
Key Investors in EBR Systems
Split Rock Partners
Split Rock Partners is a venture capital firm that invests in leading software, Internet services, and healthcare companies across all stages of development. They focus on cloud services, enterprise software and infrastructure, analytics and big data, and marketing technology. The firm is dedicated to supporting entrepreneurs by building strong relationships and working with management teams to address scaling challenges.
Delphi Ventures
Delphi Ventures is a venture capital firm that has focused on early stage investing in medical devices and biotechnology for two decades. With more than $850 million in committed capital, Delphi Ventures has funded over 150 companies. More than 90 of Delphi's portfolio companies have either completed an initial public offering or have been acquired by a leading healthcare corporation.
Ascension Ventures
Ascension Ventures is a strategic healthcare venture firm with four funds and more than $800 million in capital under management. The firm was launched in 2001 by Ascension, one of the nation's largest Catholic and non-profit health systems, and today invests on behalf of twelve of the nation's leading community health systems.
What's next for EBR Systems?
With the recent major strategic investment, EBR Systems is well-positioned to further scale its operations and expand the reach of its WiSE CRT system. The company's trajectory suggests a focus on clinical validation, market adoption, and potentially further product development to address unmet needs in the cardiac device market. Future growth will likely involve strengthening its commercial infrastructure and forging new partnerships within the healthcare ecosystem. The sustained capital injections indicate a strong belief in the company's long-term vision and its capacity to disrupt the cardiac pacing landscape.
See full EBR Systems company page
